Interestingly, we found that four of the markers best suited to distinguish cases from controls in our study were the already well-known colorectal cancer markers IKZF1, SFRP1, SFRP2 and VIM [6, 7]. This evidence concerns the gene SFRP2 and colorectal cancer.